With the rapid increase in interest from international markets for the drug and medical device industries in the Indian market, the various bodies governing healthcare are aiming to tighten regulations with an interest on patient safety. Pertaining on the issue of storage temperature on medicine labels, the Indian Pharmaceuticals Association (IPA) wants the Drug Controller General of India (DCGI) to formalize some guidelines. During a cross country study, the IPA found that most of the products do not have proper labeling and some surprisingly don’t even have the label for storage instructions. To solve this non-uniformity with the labels, the IPA has strictly said it should be made mandatory to have labels of minimum storage temperature and medical products without such labels must be terminated from the Indian market.
The DCGI is controlled by the Drugs and Cosmetics Act of 1945. Medical devices were largely unregulated since its inception. Since 2009, medical device regulations have been separated from pharmaceutical regulations. Clearly defined labeling requirements for medical devices were formulated in 2014 and constant updates based on panels such as IPA, medical device advisory boards are being made.
The IPA also insists a clear-cut temperature specification as current labeling doesn’t specify proper temperature as it reads ‘room temperature’, ‘store in cool place’ which is very confusing and ineffective as different parts of the country will have different climates. The general secretary of the IPA, Kaushik Desai said: “There is should be clear mention to room temperature which should include range of both upper and lower temperature to avoid all the non-needed statements in the label which confuses the people.
He added “The guidelines for the storage temperature labels should be structured on a priority considering the risks involved. The steps for implementing the proposed GDP by DTAB should also be taken by the CDSCO immediately.”
On February 2, 2017 The Ministry of Health and Family Welfare has announced Medical Devices Rules, 2017 that separates regulatory norms for manufacturing medical devices from drugs. The rules will come into effect from January […]Read More
Maharashtra Food and Drug Administration (FDA) has directed all 306 blood banks in the state to submit applications of renewal of licenses by 31st December 2016 to carry out timely inspections and approvals. There are […]Read More
Indian syringes and needles market is expected to grow at a CAGR of 15% by 2020. This growth is mainly because of India’s large pool of patients, increase in healthcare expenditure, increase in healthcare awareness […]Read More
The Ministry of Health’s Food Safety Standards Authority of India has come out with quality and safety standards to regulate the standards and quality of health supplements, nutraceuticals, food (special dietary care, medicinal purpose, functional […]Read More
On Monday, Indian food safety watchdog the Food Safety and Standards Authority of India (FSSAI) announced that health supplements cannot be sold as medicines at all and also fixed the permissible limits of various ingredients […]Read More
Now a new survey shows that, natural products continue to remain top of mind for many women when it comes to the personal care beauty products. The second annual Green Beauty Barometer survey questioned more […]Read More
The United States remains the biggest market for Korean cosmetic products and nowadays Korean investors are venturing into Indian cosmetic market. The Korea Trade Investment Promotion Agency (KOTRA) launched at least 10 Korean cosmetics brands […]Read More
The first Medical Device Regulatory Summit in India is being held at Holiday Inn Mumbai International Airport on 29 November 2016. Morulaa HealthTech is pleased to partner at this event. Medical Device Regulatory Summit 2016, […]Read More